Details of the Drug Reposition

General Information of This Drug (ID: DM1NOEK)

Drug Name
Metreleptin   DM1NOEK

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Congenital generalized lipodystrophy DIS4XF8N N.A. Approved [1]
Acquired generalized lipodystrophy DISHR0EB N.A. Approved [1]
Diabetic complication DIS4S2FC 5A2Y Approved [2]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acquired partial lipodystrophy DISWXX4G N.A. Investigative [1]
------------------------------------------------------------------------------------

References

1 Lipodystrophy Syndromes. Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7333).